S2E-14190-63965
3 vaccinations
3 coded responses
19 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 466 / IN
- Registered
- 2021-02-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-10
Registered in v-safe
-
2021-02-10
Dose 1 — Pfizer-BioNTech
-
2021-02-10
Health check-in — day 0, dose 1Feeling: Poor · Site: Pain · Chills, Muscle or body aches, NauseaAdult check-in
-
2021-02-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-02-11
-
2021-02-15
Survey response — days 1–6 daily, dose 1MedDRA: Pregnancy — Feeling: Good · NauseaFree text: 17 weeks pregnantMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Muscle or body aches, NauseaAdult check-in
- 2021-02-19
- 2021-02-26
-
2021-03-03
Dose 2 — Pfizer-BioNTech
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-09
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-04-07
- 2021-09-01
- 2022-03-03
-
2022-04-09
Dose 3 — Pfizer-BioNTech
- 2022-04-23
-
2022-05-08
Survey response — day 28, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2024-11 · check-in free text available
-
2022-05-21
Survey response — day 42, dose 3MedDRA: Chills, Cough, Fatigue, Nausea, Pain, Sneezing — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Nausea, chills, sneezing, exhaustion, coughing, fatigue, soreness,MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-10 | Pfizer-BioNTech | |
| 2 | 2021-03-03 | Pfizer-BioNTech | |
| 3 | 2022-04-09 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): 17 weeks pregnant
Release 11 — day 28, dose 3
Symptoms: None
Release 11 — day 42, dose 3
Symptoms: Nausea, chills, sneezing, exhaustion, coughing, fatigue, soreness,
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | No adverse event | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release